Precision-cut human liver slice cultures as an immunological platform
- PMID: 29408707
- PMCID: PMC6689534
- DOI: 10.1016/j.jim.2018.01.012
Precision-cut human liver slice cultures as an immunological platform
Abstract
The liver is the central metabolic organ in the human body, and also plays an essential role in innate and adaptive immunity. While mouse models offer significant insights into immune-inflammatory liver disease, human immunology differs in important respects. It is not easy to address those differences experimentally. Therefore, to improve the understanding of human liver immunobiology and pathology, we have established precision-cut human liver slices to study innate immunity in human tissue. Human liver slices collected from resected livers could be maintained in ex vivo culture over a two-week period. Although an acute inflammatory response accompanied by signs of tissue repair was observed in liver tissue following slicing, the expression of many immune genes stabilized after day 4 and remained stable until day 15. Remarkably, histological evidence of pre-existing liver diseases was preserved in the slices for up to 7 days. Following 7 days of culture, exposure of liver slices to the toll-like receptor (TLR) ligands, TLR3 ligand Poly-I:C and TLR4 ligand LPS, resulted in a robust activation of acute inflammation and cytokine genes. Moreover, Poly-I:C treatment induced a marked antiviral response including increases of interferons IFNB, IL-28B and a group of interferon-stimulated genes. Therefore, precision-cut liver slices emerge as a valuable tool to study human innate immunity.
Keywords: Antiviral; Hepatocyte; Innate immunity; Liver slice culture.
Copyright © 2018 Elsevier B.V. All rights reserved.
Figures
Comment in
-
Reply to "Precision-cut human liver slice cultures as an immunological platform".J Immunol Methods. 2021 Oct;497:112814. doi: 10.1016/j.jim.2020.112814. Epub 2020 Jun 25. J Immunol Methods. 2021. PMID: 32592773 No abstract available.
References
-
- Alabraba EB, Curbishley SM, Lai WK, Wigmore SJ, Adams DH, Afford SC, 2007. A new approach to isolation and culture of human Kupffer cells. J. Immunol. Methods 326, 139–144. - PubMed
-
- Azimifar SB, Nagaraj N, Cox J, Mann M, 2014. Cell-type-resolved quantitative proteomics of murine liver. Cell Metab. 20, 1076–1087. - PubMed
-
- Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F, 2013. The burden of liver disease in Europe: a review of available epidemiological data. J. Hepatol 58, 593–608. - PubMed
-
- Boess F, Kamber M, Romer S, Gasser R, Muller D, Albertini S, Suter L, 2003. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicological Sciences 73, 386–402. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
